Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Long-term culture of human liver tissue with advanced hepatic functions.

Ng SS, Xiong A, Nguyen K, Masek M, No DY, Elazar M, Shteyer E, Winters MA, Voedisch A, Shaw K, Rashid ST, Frank CW, Cho NJ, Glenn JS.

JCI Insight. 2017 Jun 2;2(11). pii: 90853. doi: 10.1172/jci.insight.90853. [Epub ahead of print]

2.

Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.

Caro-Aguilar I, Indrawati L, Kaufhold RM, Gaunt C, Zhang Y, Nawrocki DK, Giovarelli C, Winters MA, Smith WJ, Heinrichs J, Skinner JM.

Vaccine. 2017 Feb 7;35(6):865-872. doi: 10.1016/j.vaccine.2016.12.055. Epub 2017 Jan 10. Review.

PMID:
28087148
3.

Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014.

Perti T, Lucero-Obusan CA, Schirmer PL, Winters MA, Holodniy M.

PLoS Negl Trop Dis. 2016 May 4;10(5):e0004630. doi: 10.1371/journal.pntd.0004630. eCollection 2016 May.

4.

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.

Rhee SY, Sankaran K, Varghese V, Winters MA, Hurt CB, Eron JJ, Parkin N, Holmes SP, Holodniy M, Shafer RW.

J Virol. 2016 Jun 10;90(13):6058-70. doi: 10.1128/JVI.00495-16. Print 2016 Jul 1.

5.

Are current screening protocols for chronic hepatitis B virus infection adequate?

Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M.

Diagn Microbiol Infect Dis. 2016 Jun;85(2):159-67. doi: 10.1016/j.diagmicrobio.2015.12.005. Epub 2015 Dec 17.

PMID:
27009896
6.

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

Koh C, Canini L, Dahari H, Zhao X, Uprichard SL, Haynes-Williams V, Winters MA, Subramanya G, Cooper SL, Pinto P, Wolff EF, Bishop R, Ai Thanda Han M, Cotler SJ, Kleiner DE, Keskin O, Idilman R, Yurdaydin C, Glenn JS, Heller T.

Lancet Infect Dis. 2015 Oct;15(10):1167-74. doi: 10.1016/S1473-3099(15)00074-2. Epub 2015 Jul 16.

7.

Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro.

Chivero ET, Bhattarai N, Rydze RT, Winters MA, Holodniy M, Stapleton JT.

J Gen Virol. 2014 Jun;95(Pt 6):1307-19. doi: 10.1099/vir.0.063016-0. Epub 2014 Mar 25.

8.

Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.

Kushner LE, Wendelboe AM, Lazzeroni LC, Chary A, Winters MA, Osinusi A, Kottilil S, Polis MA, Holodniy M.

PLoS One. 2013 Apr 4;8(4):e60387. doi: 10.1371/journal.pone.0060387. Print 2013.

9.

Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.

Gish RG, Yi DH, Kane S, Clark M, Mangahas M, Baqai S, Winters MA, Proudfoot J, Glenn JS.

J Gastroenterol Hepatol. 2013 Sep;28(9):1521-5. doi: 10.1111/jgh.12217.

10.

Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Bao Y, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB; A5185s Team.

Clin Infect Dis. 2013 Jul;57(2):290-7. doi: 10.1093/cid/cit195. Epub 2013 Mar 26.

11.

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.

Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez AI, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG; PEARLS study team of the ACTG.

PLoS Med. 2012;9(8):e1001290. Epub 2012 Aug 14.

12.

IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.

Osinusi A, Chary A, Winters MA, Naggie S, Masur H, Polis MA, Kottilil S, Holodniy M.

J Med Virol. 2012 Oct;84(10):1522-7. doi: 10.1002/jmv.23376.

13.

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.

Winters MA, Lloyd RM Jr, Shafer RW, Kozal MJ, Miller MD, Holodniy M.

PLoS One. 2012;7(7):e40514. doi: 10.1371/journal.pone.0040514. Epub 2012 Jul 18.

14.

Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.

Chary A, Winters MA, Eisen R, Knight TH, Asmuth DM, Holodniy M.

J Med Virol. 2012 Mar;84(3):431-7. doi: 10.1002/jmv.23210.

PMID:
22246828
15.

The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment.

Fessel WJ, Anderson B, Follansbee SE, Winters MA, Lewis ST, Weinheimer SP, Petropoulos CJ, Shafer RW.

Antiviral Res. 2011 Dec;92(3):484-7. doi: 10.1016/j.antiviral.2011.09.010. Epub 2011 Oct 4.

16.

Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques.

Winters MA, Van Rompay KK, Kashuba AD, Shulman NS, Holodniy M.

Antimicrob Agents Chemother. 2010 Oct;54(10):4059-63. doi: 10.1128/AAC.00747-10. Epub 2010 Aug 9.

17.

Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients.

Chary A, Winters MA, Kottilil S, Murphy AA, Polis MA, Holodniy M.

J Infect Dis. 2010 Sep 15;202(6):889-93. doi: 10.1086/655784.

18.

Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.

Winters MA, Chary A, Eison R, Asmuth D, Holodniy M.

J Med Virol. 2010 May;82(5):791-8. doi: 10.1002/jmv.21679.

PMID:
20336744
19.

Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance.

Balamane M, Winters MA, Dalai SC, Freeman AH, Traves MW, Israelski DM, Katzenstein DA, Klausner JD.

Open Virol J. 2010;4:88-93. doi: 10.2174/1874357901004010088. Epub 2010 May 28.

20.

Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing.

Lloyd RM Jr, Burns DA, Huong JT, Mathis RL, Winters MA, Tanner M, De La Rosa A, Yen-Lieberman B, Armstrong W, Taege A, McClernon DR, Wetshtein JL, Friedrich BM, Ferguson MR, O'Brien W, Feorino PM, Holodniy M.

J Clin Microbiol. 2009 May;47(5):1491-6. doi: 10.1128/JCM.02354-08. Epub 2009 Mar 25.

Supplemental Content

Loading ...
Support Center